ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ophthalmology, CNS (central nervous system), and oncology/hematology, today announced that its majority-owned subsidiary, AiBtl BioPharma Inc., has signed a strategic share-based land acquisition agreement with local landholders in central Taiwan. The transaction, valued at $7,666,667, involved the exchange of AiBtl shares priced at $5.00 [1] per share and secured exclusive rights to agricultural land for future pharmaceutical production.
The acquired land will be designated for the cultivation and extraction of Polygala tenuifolia (Yuan Zhi), a central ingredient in AiBtl's botanical drug candidates for Major Depressive Disorder (MDD) and Attention Deficit Hyperactivity Disorder (ADHD). The Company believes this move is key to reducing sourcing risk and supporting large-scale, high-quality production of active botanical compounds.
'This agreement is a long-term investment into securing the future of botanical drug innovation,' said Uttam Patil, Ph.D., Chief Executive Officer of ABVC. 'By locking in upstream resources in Asia, we are strengthening AiBtl's infrastructure from seed to formulation - giving our neuroscience pipeline a sustainable foundation.'
The transaction also reflects ABVC's continuing efforts to expand its physical and operational footprint in the Asia-Pacific region while enhancing value for global shareholders.
Strategic Context
Over the past year, AiBtl has continued to make steady progress in its business development involving its botanical drug candidates for MDD and ADHD—two neurological conditions with multi-billion-dollar global market potential and substantial unmet medical needs. With these developments, the announcement underscores ABVC's long-term commitment to securing upstream agricultural resources and establishing a vertically integrated supply chain from cultivation to clinical application.
Market Significance of AiBtl's CNS Drug Pipeline
MDD Drug Candidate: The MDD therapeutics market is projected to reach $14 billion by 2027, with antidepressant drug sales growing at a CAGR of 6.2%. [2] Current treatment drugs face issues like delayed onset, significant side effects, and poor compliance. [3] AiBtl's MDD candidate, based on Polygala tenuifolia extract, falls under the Botanical NDA pathway. [4] It offers a safer, long-term option with potential neuroprotective effects via NGF-related pathways, positioning it as a differentiated, high-potential out-licensing target. [5]
ADHD Drug Candidate: The ADHD market is expected to exceed $24 billion by 2032, fueled by increasing diagnoses and demand for innovative treatment solutions. [6] Existing stimulants carry addiction and misuse risks. [7] AiBtl's ADHD candidate leverages natural, non-stimulant mechanisms for neurological regulation, with strong safety profile and pediatric suitability. [8] This product holds particular appeal in Asia, where parental demand for plant-based alternatives is high. [9]
For more information, please visit www.abvcpharma.com and
For more information about ABVC and its subsidiaries, stay updated on the latest updates or visit https://abvcpharma.com. Visit https://biolite-japan.com for more information on BioLite Japan. ABVC urges its shareholders to sign up on the Company's website for the latest news alerts; visit https://abvcpharma.com/?page_id=17707
About ABVC BioPharma & Its Industry
ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus(R)) under development. For its drug products, the Company utilizes in-licensed technology from its network of world-renowned research institutions to conduct proof-of-concept trials through Phase II of clinical development. The Company's network of research institutions includes Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center. For Vitargus(R), the Company intends to conduct global clinical trials through Phase III.
Forward-Looking Statements
This press release contains 'forward-looking statements.' Such statements may be preceded by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential,' or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. None of the outcomes expressed herein are guaranteed. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our product candidates on a commercial scale on our own, or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to proceed to the next level of the clinical trials or to market our product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
This press release does not constitute an offer to sell, or the solicitation of an offer to buy any of the Company's securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company's securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
Contact:
[1] The mentioned share valuation reflects a private transaction and does not represent a public offering price or future valuation of AiBtl stock.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Xi Has 'Bowed To Reality,' Says China Analyst, Urges More Engagement Between Leaders To Resolve Trade Issues: 'No Substitute For Direct Negotiations With Trump'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As U.S. President Donald Trump and Chinese President Xi Jinping break the ice with a phone call after months of silence, analysts weigh in on what's in store for the U.S.-China trade. What Happened: The U.S. and China have been at odds over trade for a considerable period. The call signifies some advancement in establishing ground rules for a potential meeting. Jeremy Chan, Senior China Analyst at the Eurasia Group consultancy, stated that this communication suggests a level of respect from President Trump towards President Xi, reported The South China Morning Post. Trending: Start investing with eToro's CopyTrader — . However, analysts have noted that more than optimistic statements are required to resolve the deeply rooted trade differences between the two nations. Chan further noted that Xi typically consents to meetings with foreign leaders only after substantial groundwork has been laid through lower-level diplomatic efforts. "Xi has bowed to reality, like so many other foreign leaders before him, that there is no substitute for direct negotiations with Trump," stated Chan, who is also a former U.S. diplomat. On the other hand, ASPI's Wendy Cutler highlighted the complexity of the upcoming trade talks and the challenges. "The likelihood of further misunderstandings, coupled with a fundamental lack of trust, will present enormous challenges for the negotiators as they try to hammer out a deal," cautioned It Matters: This phone call comes in the wake of escalating trade tensions between the two countries. On Thursday, U.S. stocks dipped following reports of a phone call between Presidents Donald Trump and Xi Jinping, signaling a possible thaw in China trade tensions. The outreach was said to have come from the U.S. side, as per CNBC, citing Chinese state media. Earlier in May, President Trump had expressed his willingness to travel to China to meet with President Xi Jinping, emphasizing the importance of the U.S.-China relationship. In early May, the South China Morning Post reported that the U.S. and China are struggling to resume trade talks. China suggested using special envoys, but the U.S. prefers direct talks between Trump and Xi—a move China considers 'risky and uncertain.' This latest phone call could be seen as a step towards that potential meeting, and a move towards resolving the trade disputes. Baidu Inc (NASDAQ:BIDU) and Alibaba Group Holding Ltd – ADR (NYSE:BABA) climbed 1.13% and 0.43%, respectively, on Thursday. Meanwhile, Inc. (NASDAQ:JD) declined 0.72% Read Next: Nancy Pelosi Invested $5 Million In An AI Company Last Year — Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000. Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold. Image via Shutterstock This article Xi Has 'Bowed To Reality,' Says China Analyst, Urges More Engagement Between Leaders To Resolve Trade Issues: 'No Substitute For Direct Negotiations With Trump' originally appeared on
Yahoo
an hour ago
- Yahoo
Prediction: This Artificial Intelligence (AI) Stock Could Hit a $6 Trillion Valuation by 2030
Nvidia is currently the world's largest company by market cap. The semiconductor giant still has a lot of room for growth, considering the potential investment in artificial intelligence (AI) infrastructure over the next five years. Nvidia has additional catalysts coming into play that could allow it to sustain terrific growth and hit a $6 trillion valuation in the future. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) is the most valuable company in the world as of this writing, with a market cap of $3.4 trillion, and it has reached this position thanks to a tremendous rally of more than 1,500% in its stock price in the past five years. Investors will now be wondering if Nvidia has the potential to deliver more upside over the next five years following this phenomenal run. However, don't be surprised to see this semiconductor giant's shares jump higher and attain a $6 trillion valuation by the end of the decade. Let's take a closer look at the factors that could help Nvidia hit that milestone by 2030. Robust demand for Nvidia's AI chips has been the biggest reason behind the stock's terrific surge in recent years. The good part is that Nvidia continues to generate a massive amount of revenue from its AI chip business despite tackling headwinds such as export restrictions to key markets like China. This was evident from Nvidia's latest results for the first quarter of fiscal 2026 (which ended on April 27). The company's revenue shot up 69% year over year to $44.1 billion during the quarter, even though it lost $2.5 billion in revenue in fiscal Q1, owing to the restrictions on sales of its chips to China. The chipmaker also incurred a $4.5 billion inventory charge to write down the value of chips that were intended for the Chinese market. Moreover, Nvidia's fiscal Q2 revenue would take an $8 billion hit on account of the China-related restrictions. But the good part is that the company's guidance for the current quarter still calls for a 50% year-over-year increase in revenue, while its earnings are expected to increase by 44% despite anticipated loss in Chinese revenue. CEO Jensen Huang admitted on Nvidia's latest earnings conference call that the $50 billion Chinese market is now effectively closed to U.S. players such as Nvidia. Even then, analysts have increased their revenue estimates. That's not surprising, as Nvidia still has a massive sales opportunity in AI chips beyond the Chinese market. It is now entering new markets such as Saudi Arabia to build AI factories "powered by several hundred thousand of Nvidia's most advanced GPUs over the next five years," according to the company. Additionally, massive AI infrastructure projects such as Stargate, from which Nvidia has started benefiting already, could help it mitigate the lost opportunity in China. Management consulting firm McKinsey & Company predicts that AI-capable data centers could require investments worth a whopping $5.2 trillion by 2030 to build enough computing power to handle training and inference workloads. So investors would do well to look past the China-related problems that Nvidia is currently facing, as the broader opportunity in the AI data center market should be lucrative enough to help the chipmaker keep growing at a healthy pace for the next five years. Moreover, Nvidia is showing no signs of losing its grip over the AI chip market. Its data center revenue shot up an impressive 73% year over year to $39 billion in the previous quarter. That was miles ahead of Broadcom's $4 billion AI revenue and AMD's $3.7 billion data center sales in the previous quarter, the two chipmakers that are considered to be the closest to Nvidia in the AI chip race. Nvidia's data center growth was higher than the 57% growth recorded by AMD in this segment and close to the 77% growth in Broadcom's AI revenue, even though it has a much larger revenue base. This is a testament to just how popular Nvidia's AI chips are, with the company's latest generation of Blackwell processors already a major hit among cloud computing giants within two quarters of hitting the market. Even better, Nvidia has moved past just selling AI hardware. It also offers access to models that help customers train and deploy AI agents, along with other enterprise AI applications that allow customers to improve the efficiency of their large language models (LLMs). Its enterprise platforms are gaining traction in diverse industries such as cybersecurity and restaurants where companies are deploying Nvidia's solutions to streamline their operations or to build agentic AI applications. All this indicates that investors shouldn't miss the forest for the trees, as Nvidia's long-term prospects aren't dependent on just China. There is still a lot of room for growth in the AI chip market, and the company's diversification into other areas such as enterprise AI applications and automotive should be enough to power remarkable growth over the next five years. Nvidia is currently trading at 23 times sales. While that's three times the U.S. technology sector's average price-to-sales ratio, the company's dominant position in AI chips, the prospects of this market, and the other catalysts that are coming into play help justify that valuation. We have already seen in the chart that Nvidia's top line is expected to jump to $292 billion in three years. If it maintains its sales multiple at that time, it will be able to easily surpass a $6 trillion valuation in just three years, representing a big jump from current levels. However, if we assume Nvidia's top-line growth slows after fiscal 2028 to an annual rate of 15% in fiscal 2029 and 2030 from the 31% compound annual growth rate that it is forecast to clock between fiscal 2026 and 2028 (using fiscal 2025 revenue of $130.5 billion as the base), its annual revenue could jump to $386 billion after five years. If Nvidia trades at a discounted 15 times sales at that time, it could still hit a $6 trillion valuation by 2030. So, investors can still consider buying this AI stock in anticipation of more upside in the long run, as it seems capable of maintaining its healthy growth rate over the next five years. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy. Prediction: This Artificial Intelligence (AI) Stock Could Hit a $6 Trillion Valuation by 2030 was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Up 725% in 10 Years: Why This Could Be Wall Street's Next Big Stock Split
Stocks tend to get a boost when management announces a stock split. This stock has produced excellent operating results, and a split could signal confidence from management. Advances in artificial intelligence could unlock a lot of value for the business over the next few years. 10 stocks we like better than Meta Platforms › Some might argue a stock split is merely cosmetic. Existing owners still own the same percentage of the company they did before the split and the business continues to operate just as it had before. The only difference is new buyers can now buy even smaller portions of the business, and shareholders can sell off smaller portions. But a stock split, which usually comes after a prolonged period of gains in the stock price, can provide a useful signal from management. If management expects the price to continue climbing higher, it's more likely to split the stock. If it thought the stock was overvalued, it might hold off. As a result, stock prices seem to move higher when management announces a stock split. In that case, it's best to buy a stock ahead of management's decision. And one stock, up 725% in the last decade, is a great buy at its current price whether management decides to split its shares or not. There are a few factors that go into the decision to split shares. For one, the stock probably has a relatively high price, making it difficult for retail investors to buy whole shares. But there are other factors at play as well, including how the company uses share-based compensation and how much of the business is owned by smaller investors. When all of them align, a stock split makes a lot of sense. That's why Meta Platforms (NASDAQ: META) looks poised to split its shares in the near future. Not only does the stock trade well above $650 per share, it pays out over $16 billion in share-based compensation per year and 20% of the shares outstanding are held by retail investors. Meta has been one of the most successful businesses over the last 10 years. After several major acquisitions -- Instagram, WhatsApp, Oculus -- the company has grown its user base across all of its apps while pushing the frontier of virtual reality and augmented reality. Its recent focus on artificial intelligence (AI) promises to unlock value across its properties, including WhatsApp and Reality Labs (its AR/VR business segment). Thanks to strong execution, management has grown its annual advertising revenue from $11.5 billion in 2014 to $161 billion in 2024. That's an average compound annual growth rate of 30%. But there's a lot more growth ahead for Meta Platforms, and there's a good reason management may want to split its stock. Meta sees several opportunities to grow faster over the long run than its smaller competitors and many other tech companies of its size. As mentioned, the key to unlocking a ton of value for Meta is its work in advancing artificial intelligence. To that end, management plans to spend around $70 billion this year on capital expenditures, mostly focused on building and outfitting data centers for AI training and inference. AI has the power to unlock a ton of value for Meta's feed-based apps. The company is working on AI agents that can create and manage ad campaigns for any business with any product, including ad creatives customized for each user. That could increase the value of ads on Facebook and Instagram, open the door for more small businesses to advertise, and increase the total share of ad spend flowing to Meta. And this isn't some far-off dream, the company expects to roll out that feature by the end of next year, according to a report from The Wall Street Journal. Meta also has an opportunity to build chatbot agents for businesses within WhatsApp and Messenger, offering individualized sales and customer service reps. That could further increase interest in Meta's click-to-message ad units, which were a $10 billion business in its most recently reported quarter. One analyst thinks Meta could generate $100 billion per year from chat agents by charging businesses directly. Lastly, Meta can use generative AI to take full advantage of the immersive and personalized nature of virtual or augmented reality. It's already seen success integrating its Meta AI chatbot into a pair of glasses, giving the AI access to visuals. The next step is to let AI interact with the world virtually through augmented reality to help users understand what they're looking at, make decisions, or just have fun. Those uses could rapidly push AR and VR into the mainstream. Importantly, Meta's stock trades at a reasonable valuation. Investors can buy shares for 26 times forward earnings expectations. It's worth noting that Meta's earnings growth expectations over the next few years are weighed down by the increased depreciation expense from the last few years' increase in capital expenditures related to AI. But if those AI investments pay off as expected, earnings growth should accelerate as it leverages its innovation across its applications and devices. Management could signal confidence in those efforts paying off by announcing a stock split, but it's worth owning at this price, whether or not a split ever materializes. Before you buy stock in Meta Platforms, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Meta Platforms wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor's total average return is 997% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Adam Levy has positions in Meta Platforms. The Motley Fool has positions in and recommends Meta Platforms. The Motley Fool has a disclosure policy. Up 725% in 10 Years: Why This Could Be Wall Street's Next Big Stock Split was originally published by The Motley Fool
